These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33527618)

  • 1. The role of biologic treatment in special scenarios in hidradenitis suppurativa: Facial and nape phenotype, dissecting cellulitis of the scalp, and lymphedema.
    Sanchez-Diaz M; Martinez-Lopez A; Salvador-Rodriguez L; Montero-Vilchez T; Arias-Santiago S; Molina-Leyva A
    Dermatol Ther; 2021 Mar; 34(2):e14829. PubMed ID: 33527618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent hidradenitis suppurativa, inflammatory acne, dissecting cellulitis of the scalp, and pyoderma gangrenosum in a 16-year-old boy.
    Koshelev MV; Garrison PA; Wright TS
    Pediatr Dermatol; 2014; 31(1):e20-1. PubMed ID: 24118007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting cellulitis (Perifolliculitis Capitis Abscedens et Suffodiens): a comprehensive review focusing on new treatments and findings of the last decade with commentary comparing the therapies and causes of dissecting cellulitis to hidradenitis suppurativa.
    Scheinfeld N
    Dermatol Online J; 2014 May; 20(5):22692. PubMed ID: 24852785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting cellulitis of the scalp associated with peripheral and axial spondyloarthritis: report of a case and review of the literature.
    Zagelbaum Ward NK; Jun JA; Vecerek N; Donaldson M; Quismorio FP
    Clin Rheumatol; 2022 Aug; 41(8):2553-2560. PubMed ID: 35460009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis.
    Scheinfeld N
    Dermatol Online J; 2013 Jun; 19(6):18558. PubMed ID: 24011308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case of Dissecting Cellulitis of the Scalp, Hidradenitis Suppurativa, and Conglobate Acne Successfully Treated with Secukinumab.
    Schettini N; Marzola E; Pacetti L; Cavaliere S; Bettoli V
    Skin Appendage Disord; 2024 Jun; 10(3):232-235. PubMed ID: 38835714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Up-to-Date Approach to the Management of Dissecting Cellulitis.
    Nussbaum D; Desai S; Nelson K; Saardi K; Friedman A
    J Drugs Dermatol; 2022 Jul; 21(7):800-802. PubMed ID: 35816064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shorter time to initiation of biologic therapy in the setting of a hidradenitis suppurativa specialty clinic.
    Kearney N; O'Donohoe S; Hughes R; Kirby B
    Clin Exp Dermatol; 2023 Sep; 48(10):1149-1151. PubMed ID: 37256275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical hidradenitis suppurativa.
    Naasan H; Affleck A
    Clin Exp Dermatol; 2015 Dec; 40(8):891-3. PubMed ID: 25917371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hidradenitis suppurativa of the nape: Description of an atypical phenotype related to severe early-onset disease in men.
    Agut-Busquet E; Romaní J; Ribera M; Luelmo J
    J Dermatol; 2019 Feb; 46(2):149-153. PubMed ID: 30561771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging drugs for the treatment of hidradenitis suppurativa.
    Folkes AS; Hawatmeh FZ; Wong A; Kerdel FA
    Expert Opin Emerg Drugs; 2020 Sep; 25(3):201-211. PubMed ID: 32667213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic Treatment for Hidradenitis Suppurativa.
    Flood KS; Porter ML; Kimball AB
    Am J Clin Dermatol; 2019 Oct; 20(5):625-638. PubMed ID: 31140067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adalimumab Treatment in Women With Moderate-to-Severe Hidradenitis Suppurativa from the Placebo-Controlled Portion of a Phase 2, Randomized, Double-Blind Study.
    Gottlieb A; Menter A; Armstrong A; Ocampo C; Gu Y; Teixeira HD
    J Drugs Dermatol; 2016 Oct; 15(10):1192-1196. PubMed ID: 27741335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic therapies for the treatment of hidradenitis suppurativa.
    Rosales Santillan M; Morss PC; Porter ML; Kimball AB
    Expert Opin Biol Ther; 2020 Jun; 20(6):621-633. PubMed ID: 32077334
    [No Abstract]   [Full Text] [Related]  

  • 15. Unilateral Breast Skin Changes in Patient With Hidradenitis Suppurativa: Malignancy Versus Lymphedema.
    Ederle A; Dreher K; Valdes-Rodriguez R
    Cureus; 2021 Jul; 13(7):e16232. PubMed ID: 34367830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphedema in patients with hidradenitis suppurativa: a systematic review of published literature.
    Micieli R; Alavi A
    Int J Dermatol; 2018 Dec; 57(12):1471-1480. PubMed ID: 30105858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hidradenitis supparativa complicated by penoscrotal lymphedema and renal amyloidosis.
    Rubaian NFB; Al Zamami HF; Almuhaidib SR; Al Breiki SH
    Saudi Med J; 2022 Jul; 43(7):751-754. PubMed ID: 35830985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azathioprine in hidradenitis suppurativa with inflammatory phenotype: a case series of 11 patients.
    López Riquelme I; Fernández Ballesteros MD; Perea Polak A; Serrano Ordoñez A; Martínez Pilar L
    Int J Dermatol; 2023 Oct; 62(10):1300-1303. PubMed ID: 37548251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of medical treatments for pediatric hidradenitis suppurativa: A systematic review.
    Masson R; Ma E; Parvathala N; Shih T; Atluri S; Hogeling M; Hughes M; Sayed CJ; Shi VY; Hsiao JL
    Pediatr Dermatol; 2023; 40(5):775-788. PubMed ID: 37525978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hidradenitis suppurativa in the pediatric population.
    Liy-Wong C; Pope E; Lara-Corrales I
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S36-41. PubMed ID: 26470613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.